Market doesn't like delays (Or Biotech's at the moment - its all battery metals).
NYR have been quite transparent with timelines and there is no material change in todays Qtly.
Fully funded through the trials is fantastic (already known) - but good to reiterate as no cap raise risk holding it back leading into commencement of trials..
As early stage biotechs go, the PCSK-9 trial presents a very attractive risk reward proposition (high probability of favourable trial results and low mkt cap).
Efficacy from mouse models for statins and prior PCSK-9 studies translated very well to human trials, Efficacy is not likely to be an issue at all... So it really is a safety trial with a qn on how big is the reduction in LDL.
- Forums
- ASX - By Stock
- Ann: Nyrada Quarterly Activities Report & Appendix 4C
Market doesn't like delays (Or Biotech's at the moment - its all...
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NYR (ASX) to my watchlist
|
|||||
Last
4.9¢ |
Change
-0.009(15.5%) |
Mkt cap ! $8.928M |
Open | High | Low | Value | Volume |
5.9¢ | 5.9¢ | 4.8¢ | $113.9K | 2.187M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 208163 | 4.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.1¢ | 25000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 208163 | 0.049 |
2 | 190000 | 0.045 |
1 | 35000 | 0.041 |
1 | 200000 | 0.035 |
2 | 174995 | 0.020 |
Price($) | Vol. | No. |
---|---|---|
0.051 | 25000 | 1 |
0.053 | 9000 | 1 |
0.054 | 185203 | 1 |
0.056 | 32300 | 1 |
0.062 | 18181 | 1 |
Last trade - 15.46pm 09/07/2024 (20 minute delay) ? |
Featured News
NYR (ASX) Chart |